Article
Phenotypic Models of CAR T-Cell Activation Elucidate the Pivotal Regulatory Role of CAR Downmodulation.
Molecular cancer therapeutics - 1 May 2021
Greenman Raanan, Pizem Yoav, Haus-Cohen Maya, Horev Guy, Denkberg Galit, Shen-Orr Shai, Rubinstein Jacob, Reiter Yoram
Abstract excerpt
Adoptive cell immunotherapy with chimeric antigen receptor (CAR) showed limited potency in solid tumors, despite durable remissions for hematopoietic malignancies. Therefore, an investigation of ways to enhance the efficacy of CARs' antitumor response has been engaged upon. We previously examined the interplay between the biophysical parameters of CAR binding (i.e., affinity, avidity, and antigen density), as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
